The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic and a burden to …

A 74-year-old man with COVID-19 was admitted and experienced progressive dyspnoea
while receiving supplemental oxygen via high-flow nasal cannula (HFNC). A CT of the …

Background: Pneumomediastinum, subcutaneous emphysema and pneumothorax are not
rarely observed during the COVID-19 pandemic. Such complications can worsen gas …

A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal
cannula and review of the literature: Is this a “spontaneous” complication? - Cancelliere - 2021 …

Interventions: All patients had oxygen treatment with HFNC, as well as regular treatment of
antivirals and traditional Chinese medicine. Outcomes: Two patients survived after …

In recent years, high flow nasal cannula (HFNC) is a respiratory support system that has
become prominent in the treatment of respiratory failure. HFNC provides higher …

Data on patient-related factors associated with pneumothorax among critically ill patients
with COVID-19 pneumonia is limited. Reports of spontaneous pneumothorax in patients with …

Background The clinical features and outcomes of mechanically ventilated patients with
COVID-19 infection who develop a pneumothorax has not been rigorously described or …

Aim: Pneumothorax (PNX), pneumomediastinum (PMD) and subcutaneous emphysema
(SCE) are COVID-19 complications related to positive-pressure ventilation. We analyzed the …

Background: During the first wave of COVID-19, the large influx of severely ill patients led to
insufficient availability of beds in intensive care units and a shortage of ventilators. The …